Media, investors, advocacy organizations and others, please contact us here.
For US healthcare professionals only
The purpose of this Travere Therapeutics Medical Affairs website is to support healthcare professionals with scientific information. This website is also a channel for US healthcare professionals to submit questions or connect with Travere Therapeutics US healthcare professionals. The information provided is for educational purposes only and is not intended to promote any products. By continuing to use this site you are acknowledging that you are a US healthcare professional
The Humanistic Burden of Rare Kidney Diseases: Understanding the Impact of Focal Segmental Glomerulosclerosis (FSGS) and Immunoglobulin A Nephropathy (IgAN) on Patients and Caregivers Study (HONUS): Preliminary Results for IgAN in the United States (US)
The Treatment Effect of RAS Blockade on Proteinuria in IgA Nephropathy Patients as a Surrogate for Renal Events and Decline in eGFR: An Analysis of Randomized Controlled Trials
DEFINE: Physicians – An International Delphi Survey to Identify Consensus in the Care of Patients with Focal Segmental Glomerulosclerosis / Idiopathic Syndrome
Humanistic Burden or Rare Kidney Diseases: Understanding the Impact of FSGS and IgAN on Patients and Caregivers Study (HONUS) Rationale and Study Design
The Dual Endothelin Angiotensin Receptor Antagonist (Deara) Sparsentan Protects from Glomerular Hypercellularity and Associated Immune/Inflammatory Gene-Network-Activity in a Modal of Iga Nephropathy (Igan)